Skip to main content Skip to footer

News & Inisghts

Diagnostic Database

Diagnostics 101
Digital Cognitive Assessments
CSF & PET
Blood-Based Biomarkers

Diagnostics 101
Digital Cognitive Assessments
CSF & PET
Blood-Based Biomarkers

News & Inisghts

Diagnostic Database

Diagnostics 101
Digital Cognitive Assessments
CSF & PET
Blood-Based Biomarkers

Category: Research Articles

February 17, 2026
February 4, 2026
January 28, 2026
January 16, 2026
January 8, 2026
September 18, 2025
September 13, 2024
July 28, 2024
June 12, 2024
June 12, 2024
Anti-amyloid treatments for early symptomatic Alzheimer disease have recently become clinically available in some countries, which has greatly increased the…

1
2
→

Follow Us

Useful Links

Diagnostic Database
Diagnostics 101
Blood-Based Biomarkers
Digital Cognitive Assessments
CSF & PET

support

News & Insights
About Us
Contact Us

© 2026 UsAgainstAlzheimer’s. All rights reserved.

The Global CEO Initiative on Alzheimer’s Disease (CEOi) is a collaboration of leading private sector organizations dedicated to accelerating progress in the fight against Alzheimer's disease. By leveraging the collective influence of its members, CEOi works to shape global dialog, drive innovations in diagnostics and treatment, and increase global awareness of Alzheimer's.

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.